DraftKings is quietly building a second business Wall Street is only now pricing in

DraftKings revealed that its prediction-markets platform has reached $1.3 billion in annualized trading volume, a figure that surprised even optimistic observers and sent the stock up more than 11 percent.

The number matters not just for its size but for what it signals: DraftKings is no longer a one-product company, and investors who wrote it off as a crowded-market sports-betting play may need to rethink the whole thesis.

Rivian's launch day is a reminder that good news alone cannot hold a falling stock

Rivian began delivering its R2 SUV on Tuesday and pulled forward its entry-level model by several months, a double dose of positive news for a company that has staked its future on expanding beyond its expensive original truck lineup.

The stock fell nearly 7 percent anyway, which tells you that the market is still unconvinced Rivian can turn milestones into margins at the scale it needs to survive.

The Palantir NHS review tests whether government AI contracts are as durable as they look

Britain's National Health Service launched a formal review of its data contract with Palantir, with politicians pushing to invoke a break clause when the initial term ends in early 2027, putting one of the company's most prominent public-sector relationships in genuine jeopardy.

For a company whose entire pitch rests on being the trusted AI partner governments cannot afford to replace, losing a marquee health-system client would be a reputational hit that goes well beyond the revenue line.